Apixaban anti-Xa level monitoring in treatment of acute upper extremity deep vein thrombosis for patient on chronic hemodialysis: a case report

Apixaban anti-Xa level monitoring in treatment of acute upper extremity deep vein thrombosis for patient on chronic hemodialysis: a case report

Abstract Background Patients on dialysis are at higher risk of major bleeding and recurrent thrombosis creating acute venous thromboembolism (VTE) treatment challenges. DOACs represent an interesting option but there are concerns of bioaccumulation and increased bleeding risk. Anti-Xa trough levels...

Full description

Bibliographic Details
Main Authors: Guillaume Roberge, Philip Stephen Wells
Format: Article
Language:English
Published: BMC 2021-04-01
Series:Thrombosis Journal
Subjects:
Venous thromboembolism
Apixaban
Anti-Xa
Dialysis, end-stage renal disease
Online Access:https://doi.org/10.1186/s12959-021-00277-8

Internet

https://doi.org/10.1186/s12959-021-00277-8

Similar Items